BiTP demonstrates potent anti-tumor effects by reducing collagen deposition, enhancing CD8 + T cell penetration in the tumor microenvironment and increasing tumor T lymphocyte infiltration [30]. The gene discussed is CD8A; the disease is neoplasm.